Advertisement
U.S. Markets closed

medmix AG (MEDX.SW)

Swiss - Swiss Delayed Price. Currency in CHF
9.71-0.05 (-0.51%)
At close: 05:31PM CET
Currency in CHF

Valuation Measures4

Market Cap (intraday) 398.10M
Enterprise Value 621.30M
Trailing P/E 1.49k
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.90
Price/Book (mrq)0.86
Enterprise Value/Revenue 1.30
Enterprise Value/EBITDA 8.36

Trading Information

Stock Price History

Beta (5Y Monthly) 0.79
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.56
52 Week Low 39.25
50-Day Moving Average 39.92
200-Day Moving Average 313.59

Share Statistics

Avg Vol (3 month) 373.29k
Avg Vol (10 day) 347.98k
Shares Outstanding 540.79M
Implied Shares Outstanding 6N/A
Float 823.99M
% Held by Insiders 140.72%
% Held by Institutions 125.15%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.5
Forward Annual Dividend Yield 45.24%
Trailing Annual Dividend Rate 30.50
Trailing Annual Dividend Yield 35.12%
5 Year Average Dividend Yield 4N/A
Payout Ratio 45,000.00%
Dividend Date 3Apr 30, 2024
Ex-Dividend Date 4Apr 26, 2024
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -0.37%
Operating Margin (ttm)5.80%

Management Effectiveness

Return on Assets (ttm)1.03%
Return on Equity (ttm)-0.21%

Income Statement

Revenue (ttm)479.7M
Revenue Per Share (ttm)11.35
Quarterly Revenue Growth (yoy)-2.80%
Gross Profit (ttm)N/A
EBITDA 63.5M
Net Income Avi to Common (ttm)-1.8M
Diluted EPS (ttm)-0.05
Quarterly Earnings Growth (yoy)-28.80%

Balance Sheet

Total Cash (mrq)140.7M
Total Cash Per Share (mrq)3.45
Total Debt (mrq)363.9M
Total Debt/Equity (mrq)77.34
Current Ratio (mrq)1.48
Book Value Per Share (mrq)11.30

Cash Flow Statement

Operating Cash Flow (ttm)69.3M
Levered Free Cash Flow (ttm)37.14M